BioNano Genomics Inc (BNGO)

BioNano Genomics (BNGO) Stock Price & Analysis


BNGO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.19 - $22.90
Previous Close$1.66
Average Volume (3M)915.62K
Market Cap
Enterprise Value$8.30M
Total Cash (Recent Filing)$63.60M
Total Debt (Recent Filing)$10.14M
Price to Earnings (P/E)-0.2
Mar 07, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.98
Shares Outstanding38,840,337
10 Day Avg. Volume1,334,395
30 Day Avg. Volume915,619
Standard Deviation0.80
Financial Highlights & Ratios
Price to Book (P/B)0.74
Price to Sales (P/S)2.32
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.25
Enterprise Value/Gross Profit1.40
Enterprise Value/Ebitda-0.04
Price Target Upside281.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3



Ownership Overview

4.50% Mutual Funds
7.57% Other Institutional Investors
87.93% Public Companies and Individual Investors


What was BioNano Genomics Inc’s price range in the past 12 months?
BioNano Genomics Inc lowest stock price was $1.19 and its highest was $22.90 in the past 12 months.
    What is BioNano Genomics Inc’s market cap?
    Currently, no data Available
    When is BioNano Genomics Inc’s upcoming earnings report date?
    BioNano Genomics Inc’s upcoming earnings report date is Mar 07, 2024 which is in 96 days.
      How were BioNano Genomics Inc’s earnings last quarter?
      BioNano Genomics Inc released its earnings results on Nov 08, 2023. The company reported -$3.22 earnings per share for the quarter, missing the consensus estimate of -$0.97 by -$2.25.
        Is BioNano Genomics Inc overvalued?
        According to Wall Street analysts BioNano Genomics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does BioNano Genomics Inc pay dividends?
          BioNano Genomics Inc does not currently pay dividends.
          What is BioNano Genomics Inc’s EPS estimate?
          BioNano Genomics Inc’s EPS estimate is -$0.85.
            How many shares outstanding does BioNano Genomics Inc have?
            BioNano Genomics Inc has 38,840,336 shares outstanding.
              What happened to BioNano Genomics Inc’s price movement after its last earnings report?
              BioNano Genomics Inc reported an EPS of -$3.22 in its last earnings report, missing expectations of -$0.97. Following the earnings report the stock price went down -2.206%.
                Which hedge fund is a major shareholder of BioNano Genomics Inc?
                Among the largest hedge funds holding BioNano Genomics Inc’s share is GMT Capital Corp. It holds BioNano Genomics Inc’s shares valued at 2M.


                  Company Description

                  BioNano Genomics Inc

                  BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.


                  Top 5 ETFs holding BNGO

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Up to five ETFs with an Outperform Smart Score that hold BNGO. The ETFs are listed according to market value of BNGO within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Guardant Health

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis